GENOME DIAGNOSTICS
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests and services, analysis software and education. The company is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation offering high resolution HLA typing methods for Sanger and NGS techniques.
GENOME DIAGNOSTICS
Industry:
Biotechnology Health Diagnostics Medical Software
Founded:
2005-03-01
Status:
Active
Contact:
+31 (0)30 252 3799
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Employees Featured
Founder
Investors List
Ampersand Capital Partners
Ampersand Capital Partners investment in Private Equity Round - Genome Diagnostics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-29 | Scope Biosciences | Genome Diagnostics investment in Seed Round - Scope Biosciences | 1000 K EUR |
More informations about "Genome Diagnostics"
Clinical Laboratory Genetics - University Health Network
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education …See details»
Laboratory Genetics - University Health Network
An Overview of Genome Organization and How We …
Visualizing Genome Organization. Until the advent of molecular techniques such as 3C and its high-throughput derivatives, the predominant method for determining nuclear organization and chromatin conformation was FISH. This …See details»
What we do - Quest Diagnostics
Laboratory diagnostics are fundamental to your health and the health of our communities, but there’s so much more we can do. Today, we’re leading the way in advanced gene-based and …See details»
Introduction - Genome-Based Diagnostics - NCBI Bookshelf
The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. …See details»
Backgrounder - Genome Canada
To accomplish this, the Provincial Health Services Authority’s Genome Diagnostics Laboratory and Provincial Medical Genetics Program, based at BC Children’s and BC ... Receptor Leader …See details»
Optimization and Implementation of a Clinical Genome-Wide …
Fortunately, genome-wide sequencing (GWS), in the form of exome sequencing (ES) and genome sequencing (GS), has transformed our ability to achieve a timely diagnosis for rare …See details»
Genome-Based Diagnostics - NCBI Bookshelf
Dec 27, 2013 Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology is the summary of a workshop convened in May 2012 by the Roundtable on Translating Genomic-Based Research for Health and the …See details»
Comparing genome sequencing technologies to improve rare …
Background: Genome-wide sequencing has emerged as a promising strategy for the timely diagnosis of rare diseases, but it is not yet available as a clinical test performed in Canadian …See details»
Comparing genome sequencing technologies to improve rare …
May 24, 2022 Findings will inform provincial and cross-provincial policy related to the long-term organization, delivery and reimbursement of clinical-grade genome diagnostics for rare …See details»
Clinical Laboratory Genetics - University Health Network
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and …See details»
Comparing genome sequencing technologies to improve rare …
Apr 1, 2022 Findings will inform provincial and cross-provincial policy related to the long-term organization, delivery and reimbursement of clinical-grade genome diagnostics for rare …See details»
Genome sequencing as a diagnostic test - PMC - PubMed Central …
Genome sequencing: this approach offers myriad advantages as a single comprehensive test. Current short-read genome sequencing can reliably detect sequence, structural and copy …See details»
Exome and genome sequencing for rare genetic disease diagnosis: …
Nov 1, 2023 Over the past 12 years, exome sequencing and genome sequencing (ES/GS) technologies have transitioned from a research method used to identify new etiologies of rare …See details»
Genome Diagnostics - Crunchbase Investor Profile & Investments
Genome Diagnostics was acquired by Eurobio-Scientific for €135M on Aug 17, 2022. This deal was done in Cash. Transaction Name . Genome Diagnostics acquired by Eurobio-Scientific . …See details»
GenoMe Diagnostics - Crunchbase Company Profile & Funding
When was the last funding round for GenoMe Diagnostics? GenoMe Diagnostics closed its last funding round on Mar 3, 2023 from a Seed round. Who are GenoMe Diagnostics 's …See details»
Chromosomes in the genomic age. Preserving cytogenomic …
In Supplementary Box 1 and Supplementary Tables 1–3 we describe the huge potential of WGS in genome diagnostics. The upcoming transition to WGS will have immense benefits to the …See details»
Quest Diagnostics at 2080 Daniel Stuart Square in VA - Getlabs
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to …See details»
Home | Stat Diagnostics
At Stat Diagnostics, our mission is to empower personal and community health through precise, rapid, and reliable diagnostic testing. We are committed to innovating within the field of …See details»
Mouse genome rewriting and tailoring of three important disease …
Nov 1, 2023 Main. Genome synthesis is feasible for prokaryotes such as Escherichia coli 3, Mycoplasma 4 and eukaryotes such as Saccharomyces cerevisiae 5–10.However, …See details»